Company intelligence / Profile preview

Noesis Group

Ownership: Private
Development stage: Other

Overview

NoesisPharma operates as an independent dedicated clinical research center in Phoenix, Arizona. It specializes in conducting Phase II–IV clinical trials with current focus areas including major depressive disorder and obsessive-compulsive disorder. The company provides services to pharmaceutical sponsors seeking to advance their investigational drugs through later-stage human testing. There are no proprietary drugs or platforms owned by the company.

Therapeutic areas: Psychiatry
Industry: Contract Research Organization

Beyond the preview

Go deeper on Noesis Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noesis Group.

Explore the full profile